GoodRx HoldingsGDRX +3.70%65 Gross Margin % is 89.61% as of Mar. 2026, which is 4% below its 10-year median of 93.82. GuruFocus rates GDRX with a GF Score™ of 65/100 and a GF Value™ of $5.66 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 629 Healthcare Providers & Services companies, GoodRx Holdings ranks better than 94.59% on this metric.
The historical rank and industry rank for GoodRx Holdings's Gross Margin % or its related term are showing as below:
GDRX'
s Gross Margin % Range Over the Past 10 Years
Min: 91.08 Med: 93.82 Max: 97.58
Current: 91.83
During the past 8 years, the highestGross Margin % of GoodRx Holdings was 97.58%. The lowest was 91.08%. And the median was 93.82%.
GDRX's Gross Margin % is ranked better than 94.59% of 629
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs GDRX: 91.83
GoodRx Holdings had a gross margin of 89.61% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for GoodRx Holdings was -0.30% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
GoodRx Holdings had a gross margin of 89.61% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
GoodRx Holdings Gross Margin % Related Terms
GoodRx Holdings Gross Margin % Historical Data
* Premium members only.
The historical data trend for GoodRx Holdings's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GDRX vs OMDA, CERT, TALK: Gross Margin % Comparison
For the Health Information Services subindustry, GoodRx Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GoodRx Holdings Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GoodRx Holdings's Gross Margin % distribution charts can be found below:
* The bar in red indicates where GoodRx Holdings's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
GoodRx Holdings (GDRX) has a Gross Margin % of 89.61% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on GoodRx Holdings and its competitors. This is near median its historical median of 93.82. Over the past decade, GoodRx Holdings' Gross Margin % has ranged from 91.08 to 97.58. According to the industry distribution chart, GoodRx Holdings ranks #34 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 5.4%.
Is GoodRx Holdings' Gross Margin % too high?
GoodRx Holdings' current Gross Margin % of 89.61% is near median its 10-year median of 93.82. Over the past 10 years, this metric has ranged from a low of 91.08 to a high of 97.58. The Healthcare Providers & Services industry median Gross Margin % is 40.09. GoodRx Holdings' value of 89.61% is 123.5% above this industry median. Based on the distribution chart, GoodRx Holdings ranks #34 out of 629 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, GoodRx Holdings has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GoodRx Holdings' Gross Margin % compare to OMDA and CERT?
According to the Healthcare Providers & Services industry distribution chart, GoodRx Holdings ranks #34 out of 629 companies for Gross Margin %. This places GoodRx Holdings in the top 5% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.09. GoodRx Holdings' value of 89.61% is 123.5% above this benchmark. Historically, GoodRx Holdings' own Gross Margin % has ranged from 91.08 to 97.58 over the past decade. While the company's 10-year median is 93.82 vs. the industry median of 40.09, GoodRx Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GoodRx Holdings's current Gross Margin % of 89.61% is 123.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on GoodRx Holdings and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GoodRx Holdings's current Gross Margin % is 89.61%, which is near median its own 10-year median of 93.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GoodRx Holdings stock overvalued right now?
Based on GuruFocus' analysis, GoodRx Holdings (GDRX) is currently considered Possible Value Trap. The stock's GF Value™ is $5.66, compared to a current price of $2.80 — trading 50.5% below its estimated fair value. The current Gross Margin % is 89.61%, which is near median its 10-year median of 93.82 and 123.5% above the Healthcare Providers & Services industry median of 40.09. GoodRx Holdings' overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For GoodRx Holdings (GDRX), the current Gross Margin % is 89.61% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GoodRx Holdings (GDRX) Overvalued in 2026?
Based on GuruFocus' analysis, GoodRx Holdings stock appears to be undervalued.
The current stock price of $2.80 is trading 50.5% below its estimated GF Value™ of $5.66.
GuruFocus considers GoodRx Holdings to be Possible Value Trap.
Key valuation signals for GDRX:
Gross Margin %: 89.61% (near median its 10-year median of 93.82)
GF Value™: $5.66 vs. price of $2.80 (50.5% below fair value)
Industry Position: 123.5% above the Healthcare Providers & Services median (#34 of 629)
No single metric tells the full story. See the GDRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
65GF Score
Get the complete analysis for GDRX
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GDRX has been successfully added to your 
